1. Home
  2. T vs NVO Comparison

T vs NVO Comparison

Compare T & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AT&T Inc.

T

AT&T Inc.

N/A

Current Price

$22.19

Market Cap

177.8B

ML Signal

N/A

Logo Novo Nordisk A/S

NVO

Novo Nordisk A/S

N/A

Current Price

$41.55

Market Cap

199.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
T
NVO
Founded
1983
1923
Country
United States
Denmark
Employees
268000
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
177.8B
199.4B
IPO Year
2015
2001

Fundamental Metrics

Financial Performance
Metric
T
NVO
Price
$22.19
$41.55
Analyst Decision
Buy
Hold
Analyst Count
24
14
Target Price
$27.59
★ $45.63
AVG Volume (30 Days)
★ 36.7M
8.9M
Earning Date
10-21-2026
11-04-2026
Dividend Yield
★ 5.00%
3.15%
EPS Growth
★ 104.03
N/A
EPS
★ 1.33
N/A
Revenue
★ $125,648,000,000.00
N/A
Revenue This Year
$3.42
$0.06
Revenue Next Year
$0.01
$1.32
P/E Ratio
$16.62
★ $13.60
Revenue Growth
★ 2.71
N/A
52 Week Low
$19.89
$35.12
52 Week High
$29.44
$64.16

Technical Indicators

Market Signals
Indicator
T
NVO
Relative Strength Index (RSI) 48.73 57.17
Support Level $22.20 $41.05
Resistance Level $23.73 $43.24
Average True Range (ATR) 0.44 0.83
MACD 0.21 0.25
Stochastic Oscillator 83.84 68.09

Price Performance

Historical Comparison
T
NVO

About T AT&T Inc.

The wireless business contributes nearly 70% of AT&T's revenue. The company is the third-largest US wireless carrier, connecting 74 million postpaid and 17 million prepaid phone customers. Fixed-line enterprise services, which account for about 14% of revenue, include internet access, private networking, security, voice, and wholesale network capacity. Residential services, about 11% of revenue, primarily consist of in-home broadband internet access, serving 15 million customers. AT&T also has a sizable presence in Mexico, with 25 million wireless customers, but this business only accounts for 3% of revenue. The company recently sold its 70% equity stake in satellite television provider DirecTV to its partner, private equity firm TPG.

About NVO Novo Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Share on Social Networks: